SlideShare a Scribd company logo
1 of 11
Infant Hearing Loss
Tyrell Hardtke
Cochlear Implants: The Complex Debate
CDC’s 2005 Science Ambassador Program
Presentation Overview
I. Facts about infant hearing loss
A. Prevalence
B. Causes: Genetic, Non-Genetic, and
Unknown
II. Interventions and treatments for infant
hearing loss
III. Debate over cochlear implants
A. Background Information
B. Learning About the Deaf Community
IV. Essential question
Learning About Infant Hearing Loss
 Every year, about 12,000 babies are born
with hearing loss
 Causes:
1/3 genetic
1/3 non-genetic
1/3 unknown
Genetic Causes
 Gene is inherited from a parent
 400 kinds have been identified!
 Syndromic or non-syndromic
Examples:
 Usher’s Syndrome
 CX26 gene mutation
Non-Genetic and Unknown Causes
Non-Genetic:
 Trauma before or during birth
 Low birth weight
 Bacterial and viral infections (e.g., meningitis)
Unknown:
 Research is under way to reduce number of
unknown causes
 Scientists think half are genetic and half are non-
genetic
Interventions and Treatments for
Infant Hearing Loss
 Assistive technology
 Cochlear implants
 Hearing aids
 Surgery and medications
 Family support systems
 Professional staff
 Communication and language options
Cochlear Implants
 What is it?
 How does it work?
 What does it look like?
 How well can an implant recipient actually hear?
Cochlear Implants: The Debate
 Access to hearing world vs. identity within
Deaf culture (social and psychological)
 Medical ethics
 Actual effectiveness
 Not maximizing ability to perceive sounds
 Cognitive development associated with the
choice of language
The Deaf Community
 Supportive, strong
community
 Does not view hearing
loss as a disability
 Rich history and
language (e.g., ASL)
 Children with cochlear
implants may have
limited access to the
Deaf community
Essential Question:
 If you were hard of hearing, would you
want a cochlear implant? Why or why not?
References
1. EHDI Science Ambassador Program Presentation
Biernath, K., Gaffney, M., and Victor, M. June 19, 2005.
2. http://www.cdc.gov/ncbddd/ehdi/FAQ/questionsgeneral
HL.htm [6/22/05]
3. http://www.nidcd.nih.gov/health/hearing/hearingaid.
asp#4 [8/11/05]
4. http://www.asha.org/public/hearing/disorders/types.htm
[8/6/05]
5. http://www.asha.org/public/hearing/treatment/cochlear_
implant.htm [6/22/05]
6. http://www.pbs.org/wnet/soundandfury/cultu
re/deafhistory.html [8/11/05]

More Related Content

Similar to CDC 2005

Key knowledge 4.1.3
Key knowledge 4.1.3Key knowledge 4.1.3
Key knowledge 4.1.3
jkonoroth
 
consumer_report_thrive
consumer_report_thriveconsumer_report_thrive
consumer_report_thrive
Ann Conway PhD
 
Vaccine safety in oregon
Vaccine safety in oregonVaccine safety in oregon
Vaccine safety in oregon
suwick
 
Di george syndrome ppt
Di george syndrome pptDi george syndrome ppt
Di george syndrome ppt
cclarke1230
 
The effects of tuberculosis and hearing loss
The effects of tuberculosis and hearing lossThe effects of tuberculosis and hearing loss
The effects of tuberculosis and hearing loss
mphaliuj
 

Similar to CDC 2005 (19)

Key knowledge 4.1.3
Key knowledge 4.1.3Key knowledge 4.1.3
Key knowledge 4.1.3
 
Childhood immunisation: acceptance and advocacy
Childhood immunisation: acceptance and advocacyChildhood immunisation: acceptance and advocacy
Childhood immunisation: acceptance and advocacy
 
Foresight for ‘Beyond business as usual’
Foresight for ‘Beyond business as usual’Foresight for ‘Beyond business as usual’
Foresight for ‘Beyond business as usual’
 
consumer_report_thrive
consumer_report_thriveconsumer_report_thrive
consumer_report_thrive
 
Evaluation of deaf child
Evaluation of deaf childEvaluation of deaf child
Evaluation of deaf child
 
Neural tube defects
Neural tube defectsNeural tube defects
Neural tube defects
 
Spina bifida
Spina bifida Spina bifida
Spina bifida
 
Vaccine safety in oregon
Vaccine safety in oregonVaccine safety in oregon
Vaccine safety in oregon
 
2023 WORLD HEARING DAY.pptx
2023 WORLD HEARING DAY.pptx2023 WORLD HEARING DAY.pptx
2023 WORLD HEARING DAY.pptx
 
A quick look backwards and a charge going forward
A quick look backwards and a charge going forwardA quick look backwards and a charge going forward
A quick look backwards and a charge going forward
 
Presentation Hospitals and Hearing Loss
Presentation Hospitals and Hearing LossPresentation Hospitals and Hearing Loss
Presentation Hospitals and Hearing Loss
 
Research proposal
Research proposalResearch proposal
Research proposal
 
Di george syndrome ppt
Di george syndrome pptDi george syndrome ppt
Di george syndrome ppt
 
The effects of tuberculosis and hearing loss
The effects of tuberculosis and hearing lossThe effects of tuberculosis and hearing loss
The effects of tuberculosis and hearing loss
 
Hearning impairment causes_characteristics_and_special_needs
Hearning impairment causes_characteristics_and_special_needsHearning impairment causes_characteristics_and_special_needs
Hearning impairment causes_characteristics_and_special_needs
 
Baby-making : what the new reproductive treatments mean for families & society
Baby-making : what the new reproductive treatments mean for families & society Baby-making : what the new reproductive treatments mean for families & society
Baby-making : what the new reproductive treatments mean for families & society
 
Deaf-Blindness
Deaf-BlindnessDeaf-Blindness
Deaf-Blindness
 
Deaf-Blindness
Deaf-BlindnessDeaf-Blindness
Deaf-Blindness
 
congenital anomalies.pptx
congenital anomalies.pptxcongenital anomalies.pptx
congenital anomalies.pptx
 

Recently uploaded

Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose AcademicsCytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
MedicoseAcademics
 
Failure to thrive in neonates and infants + pediatric case.pptx
Failure to thrive in neonates and infants  + pediatric case.pptxFailure to thrive in neonates and infants  + pediatric case.pptx
Failure to thrive in neonates and infants + pediatric case.pptx
claviclebrown44
 
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose AcademicsConnective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
MedicoseAcademics
 
CAD CAM DENTURES IN PROSTHODONTICS : Dental advancements
CAD CAM DENTURES IN PROSTHODONTICS : Dental advancementsCAD CAM DENTURES IN PROSTHODONTICS : Dental advancements
CAD CAM DENTURES IN PROSTHODONTICS : Dental advancements
Naveen Gokul Dr
 

Recently uploaded (20)

duus neurology.pdf anatomy. phisiology///
duus neurology.pdf anatomy. phisiology///duus neurology.pdf anatomy. phisiology///
duus neurology.pdf anatomy. phisiology///
 
Top 10 Most Beautiful Russian Pornstars List 2024
Top 10 Most Beautiful Russian Pornstars List 2024Top 10 Most Beautiful Russian Pornstars List 2024
Top 10 Most Beautiful Russian Pornstars List 2024
 
Lachesis Mutus- a Homoeopathic medicinel.pptx
Lachesis Mutus- a Homoeopathic medicinel.pptxLachesis Mutus- a Homoeopathic medicinel.pptx
Lachesis Mutus- a Homoeopathic medicinel.pptx
 
Top 15 Sexiest Pakistani Pornstars with Images & Videos
Top 15 Sexiest Pakistani Pornstars with Images & VideosTop 15 Sexiest Pakistani Pornstars with Images & Videos
Top 15 Sexiest Pakistani Pornstars with Images & Videos
 
High Purity 99% PMK Ethyl Glycidate Powder CAS 28578-16-7
High Purity 99% PMK Ethyl Glycidate Powder CAS 28578-16-7High Purity 99% PMK Ethyl Glycidate Powder CAS 28578-16-7
High Purity 99% PMK Ethyl Glycidate Powder CAS 28578-16-7
 
Drug development life cycle indepth overview.pptx
Drug development life cycle indepth overview.pptxDrug development life cycle indepth overview.pptx
Drug development life cycle indepth overview.pptx
 
Negative Pressure Wound Therapy in Diabetic Foot Ulcer.pptx
Negative Pressure Wound Therapy in Diabetic Foot Ulcer.pptxNegative Pressure Wound Therapy in Diabetic Foot Ulcer.pptx
Negative Pressure Wound Therapy in Diabetic Foot Ulcer.pptx
 
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depthsUnveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
 
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose AcademicsCytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
 
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
 
Anti viral drug pharmacology classification
Anti viral drug pharmacology classificationAnti viral drug pharmacology classification
Anti viral drug pharmacology classification
 
Face and Muscles of facial expression.pptx
Face and Muscles of facial expression.pptxFace and Muscles of facial expression.pptx
Face and Muscles of facial expression.pptx
 
Report Back from SGO: What’s the Latest in Ovarian Cancer?
Report Back from SGO: What’s the Latest in Ovarian Cancer?Report Back from SGO: What’s the Latest in Ovarian Cancer?
Report Back from SGO: What’s the Latest in Ovarian Cancer?
 
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdf
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdfSEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdf
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdf
 
Sell 5cladba adbb JWH-018 5FADB in stock
Sell 5cladba adbb JWH-018 5FADB in stockSell 5cladba adbb JWH-018 5FADB in stock
Sell 5cladba adbb JWH-018 5FADB in stock
 
Failure to thrive in neonates and infants + pediatric case.pptx
Failure to thrive in neonates and infants  + pediatric case.pptxFailure to thrive in neonates and infants  + pediatric case.pptx
Failure to thrive in neonates and infants + pediatric case.pptx
 
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose AcademicsConnective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
 
CAD CAM DENTURES IN PROSTHODONTICS : Dental advancements
CAD CAM DENTURES IN PROSTHODONTICS : Dental advancementsCAD CAM DENTURES IN PROSTHODONTICS : Dental advancements
CAD CAM DENTURES IN PROSTHODONTICS : Dental advancements
 
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUELCONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
 
Overview on the Automatic pill identifier
Overview on the Automatic pill identifierOverview on the Automatic pill identifier
Overview on the Automatic pill identifier
 

CDC 2005

  • 1. Infant Hearing Loss Tyrell Hardtke Cochlear Implants: The Complex Debate CDC’s 2005 Science Ambassador Program
  • 2. Presentation Overview I. Facts about infant hearing loss A. Prevalence B. Causes: Genetic, Non-Genetic, and Unknown II. Interventions and treatments for infant hearing loss III. Debate over cochlear implants A. Background Information B. Learning About the Deaf Community IV. Essential question
  • 3. Learning About Infant Hearing Loss  Every year, about 12,000 babies are born with hearing loss  Causes: 1/3 genetic 1/3 non-genetic 1/3 unknown
  • 4. Genetic Causes  Gene is inherited from a parent  400 kinds have been identified!  Syndromic or non-syndromic Examples:  Usher’s Syndrome  CX26 gene mutation
  • 5. Non-Genetic and Unknown Causes Non-Genetic:  Trauma before or during birth  Low birth weight  Bacterial and viral infections (e.g., meningitis) Unknown:  Research is under way to reduce number of unknown causes  Scientists think half are genetic and half are non- genetic
  • 6. Interventions and Treatments for Infant Hearing Loss  Assistive technology  Cochlear implants  Hearing aids  Surgery and medications  Family support systems  Professional staff  Communication and language options
  • 7. Cochlear Implants  What is it?  How does it work?  What does it look like?  How well can an implant recipient actually hear?
  • 8. Cochlear Implants: The Debate  Access to hearing world vs. identity within Deaf culture (social and psychological)  Medical ethics  Actual effectiveness  Not maximizing ability to perceive sounds  Cognitive development associated with the choice of language
  • 9. The Deaf Community  Supportive, strong community  Does not view hearing loss as a disability  Rich history and language (e.g., ASL)  Children with cochlear implants may have limited access to the Deaf community
  • 10. Essential Question:  If you were hard of hearing, would you want a cochlear implant? Why or why not?
  • 11. References 1. EHDI Science Ambassador Program Presentation Biernath, K., Gaffney, M., and Victor, M. June 19, 2005. 2. http://www.cdc.gov/ncbddd/ehdi/FAQ/questionsgeneral HL.htm [6/22/05] 3. http://www.nidcd.nih.gov/health/hearing/hearingaid. asp#4 [8/11/05] 4. http://www.asha.org/public/hearing/disorders/types.htm [8/6/05] 5. http://www.asha.org/public/hearing/treatment/cochlear_ implant.htm [6/22/05] 6. http://www.pbs.org/wnet/soundandfury/cultu re/deafhistory.html [8/11/05]